Joshua Dennerlein
Stock Analyst at B of A Securities
(2.24)
# 1,202
Out of 4,653 analysts
87
Total ratings
46%
Success rate
-4.22%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $125.89 | -9.44% | 2 | Nov 12, 2024 | |
| FVR FrontView REIT | Initiates: Buy | $22 | $19.06 | +15.42% | 1 | Oct 28, 2024 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $31.71 | +7.22% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $26.80 | +15.67% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $78.20 | +17.65% | 1 | Sep 24, 2024 | |
| ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $307.28 | +4.46% | 3 | Sep 24, 2024 | |
| LINE Lineage | Initiates: Buy | $100 | $64.78 | +54.37% | 1 | Aug 19, 2024 | |
| CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $123.28 | +19.24% | 4 | Aug 12, 2024 | |
| MAA Mid-America Apartment Communities | Upgrades: Buy | $144 → $189 | $161.34 | +17.14% | 3 | Aug 12, 2024 | |
| EPR EPR Properties | Downgrades: Underperform | $45 → $40 | $44.94 | -10.99% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $21.65 | +15.47% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $40.06 | -22.62% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $64.45 | -17.77% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $10.92 | -45.05% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $45.19 | -26.97% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $15.68 | -4.34% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $56.90 | -8.61% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.71 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $55.41 | -2.54% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.40 | +81.82% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $13.23 | +104.08% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $22.35 | +49.89% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $33.06 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $76.65 | +1.76% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $42.36 | +10.95% | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $73 → $78 | $134.95 | -42.20% | 5 | Mar 30, 2021 |
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $125.89
Upside: -9.44%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $19.06
Upside: +15.42%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $31.71
Upside: +7.22%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $26.80
Upside: +15.67%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $78.20
Upside: +17.65%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $307.28
Upside: +4.46%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $64.78
Upside: +54.37%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $123.28
Upside: +19.24%
Mid-America Apartment Communities
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $161.34
Upside: +17.14%
EPR Properties
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $44.94
Upside: -10.99%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $21.65
Upside: +15.47%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $40.06
Upside: -22.62%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $64.45
Upside: -17.77%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $10.92
Upside: -45.05%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $45.19
Upside: -26.97%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $15.68
Upside: -4.34%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $56.90
Upside: -8.61%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $18.71
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $55.41
Upside: -2.54%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.40
Upside: +81.82%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $13.23
Upside: +104.08%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $22.35
Upside: +49.89%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $33.06
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $76.65
Upside: +1.76%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $42.36
Upside: +10.95%
Mar 30, 2021
Upgrades: Buy
Price Target: $73 → $78
Current: $134.95
Upside: -42.20%